• Home
  • The Cost-Effectiveness of Belimumab and Voclosporin for Patients with Lupus Nephritis in the United States.

The Cost-Effectiveness of Belimumab and Voclosporin for Patients with Lupus Nephritis in the United States.

Author List
Mandrik O, Fotheringham J, Ren S, Tice JA, Chapman RH, Stevenson MD, Pearson SD, Herron-Smith S, Agboola F, Thokala P
Publication
Clinical journal of the American Society of Nephrology : CJASN
Publication ID (Profile URL)
https://researcherprofiles.org/profile/263460316
Publication Year
2022
PubMed ID
35115304
Publication Title
Mandrik O, Fotheringham J, Ren S, Tice JA, Chapman RH, Stevenson MD, Pearson SD, Herron-Smith S, Agboola F, Thokala P. The Cost-Effectiveness of Belimumab and Voclosporin for Patients with Lupus Nephritis in the United States. Clin J Am Soc Nephrol. 2022 03; 17(3):385-394.